MetLife Investment Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Buy |
|
|||||
|
2025
Q1 | $164K | Sell |
|
|||||
|
2024
Q4 | $254K | Hold |
|
|||||
|
2024
Q3 | $237K | Hold |
|
|||||
|
2024
Q2 | $239K | Buy |
|
|||||
|
2024
Q1 | $200K | Hold |
|
|||||
|
2023
Q4 | $224K | Hold |
|
|||||
|
2023
Q3 | $149K | Hold |
|
|||||
|
2023
Q2 | $219K | Sell |
|
|||||
|
2023
Q1 | $278K | Hold |
|
|||||
|
2022
Q4 | $306K | Hold |
|
|||||
|
2022
Q3 | $365K | Hold |
|
|||||
|
2022
Q2 | $265K | Hold |
|
|||||
|
2022
Q1 | $392K | Buy |
|
|||||
|
2021
Q4 | $368K | Buy |
|